Browsing by Subject "Neoadjuvant"
Now showing items 1-1 of 1
-
(SAGE, 2021)Immunotherapy, in the form of immune checkpoint inhibitors (ICI), has shown activity in metastatic urothelial bladder carcinoma, resulting in the approval of several ICI agents in the first- and second-line settings. ...